Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02978547
Title The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma (Metformin 001)
Acronym Metformin 001
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Age Groups: adult | senior
Covered Countries CAN

No variant requirements are available.